Biggs Tracey D, Karavis Mark A, Harris Jacquelyn V, Hill Jessica M, Bernhards Robert C, Price Lance B, Keim Paul, Goodwin Bruce G, Sozhamannan Shanmuga
US Army Combat Capabilities Development Command, Chemical Biological Center, Aberdeen Proving Ground, Aberdeen, Maryland, USA.
DCS Corporation, Alexandria, Virginia, USA.
Microbiol Resour Announc. 2020 Apr 9;9(15):e00056-20. doi: 10.1128/MRA.00056-20.
Mutants of an attenuated (ΔANR) strain conferring increasing levels of ciprofloxacin resistance have been described. Here, we report the draft genome sequences of the parent strain (ΔANR pXO1, pXO2) and its derivatives conferring low (step 1; 0.5 μg/ml), medium (step 2; 8 to 16 μg/ml), and high (step 3; 32 to 64 μg/ml) levels of ciprofloxacin resistance.
已描述了赋予环丙沙星抗性水平不断增加的减毒(ΔANR)菌株的突变体。在此,我们报告亲本菌株(ΔANR pXO1,pXO2)及其赋予低(步骤1;0.5μg/ml)、中(步骤2;8至16μg/ml)和高(步骤3;32至64μg/ml)环丙沙星抗性水平的衍生物的基因组草图序列。